In this review, we will present the current data on commercially available molecular profiling assays in breast cancer and discuss the challenges surrounding their incorporation into routine clinical practice as prognostic and predictive tools.
Sunil Badve, MD, FRCPath
Advertisement
Articles by Sunil Badve, MD, FRCPath
Advertisement
Latest Updated Articles
- Molecular Profiling Assays in Breast Cancer: Are We Ready for Prime Time?
Published: April 15th 2012 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Pertuzumab Biosimilar in Breast Cancer Indications
2
FDA Approves Ziftomenib in R/R NPM1-Mutated Acute Myeloid Leukemia
3
Scorpion Venom Approach May Prove “Powerful” in Glioblastoma Research
4
FOG-001 Earns FDA Fast Track Designation in Desmoid Tumors
5
